Rein Therapeutics Inc. logo

RNTXRein Therapeutics Inc.

RNTX Stock Price, Valuation & Chart | Rein Therapeutics Inc.

Compare

RNTX Historical price chart

RNTX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization21.04M
PE Ratio-0.47
EPS-1.59
Trading Volume344.26K
Today's High/Low0.75/0.73
Dividend Yield0.00
52 Week High/Low2.18/0.69
Shares Outstanding27.96M
RNTX Financial Statement
RNTX Analyst ratings
RNTX Analysis & performance metrics

RNTX Company profile

Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the…

RNTX Management team

Management
Cory M. Hogaboam Ph.D.
Chief Scientific Officer
James Brian Windsor Ph.D.CEO
Chief Executive Officer, President & Director
Total 2 executives

RNTX Frequently asked questions

What is Rein Therapeutics Inc. (RNTX) Stock Price?

Current stock price of Rein Therapeutics Inc. (RNTX) stock is $0.750. The stock price is +0.37% higher in the session. The intraday range can be seen from this page. Volume of Rein Therapeutics Inc. (RNTX) stock is 344.26K.

Last updated at 01 Sept 2026, 08:00 pm.

Why is the Rein Therapeutics Inc. (RNTX) stock price going up or down today?

The stock price of Rein Therapeutics Inc. (RNTX) can change with earnings, company news, and overall market sentiment. Rein Therapeutics Inc. operates in the Healthcare / Medical - Pharmaceuticals market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Rein Therapeutics Inc. stock expensive at its current price?

Whether Rein Therapeutics Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for RNTX on this page is -0.47. EPS on this page is -1.59. Compare those figures with peers and growth expectations before deciding if the current Rein Therapeutics Inc. price is justified.

How has the stock price of Rein Therapeutics Inc. (RNTX) performed historically?

Historical performance for Rein Therapeutics Inc. (RNTX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how RNTX reacted to past earnings and market events.

Should I buy Rein Therapeutics Inc. (RNTX) stock, at this price?

Buying Rein Therapeutics Inc. (RNTX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.